Market Performance - The Chinese medicine sector rose by 0.47% on August 25, with Tianmu Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 3883.56, up 1.51%, while the Shenzhen Component Index closed at 12441.07, up 2.26% [1] Top Gainers in Chinese Medicine Sector - Tianmu Pharmaceutical (600671) closed at 19.80, up 10.00% with a trading volume of 144,000 shares and a transaction value of 271 million [1] - Jizhitang (000989) closed at 12.71, up 8.08% with a trading volume of 895,100 shares [1] - Zhendong Pharmaceutical (300158) closed at 66.80, up 7.28% with a trading volume of 1,339,500 shares [1] - Enwei Pharmaceutical (301331) closed at 39.08, up 6.95% with a trading volume of 40,600 shares [1] - New Great Pharmaceutical (002873) closed at 13.31, up 6.06% with a trading volume of 537,200 shares [1] Decliners in Chinese Medicine Sector - Jichuan Pharmaceutical (600566) closed at 26.57, down 3.45% with a trading volume of 277,600 shares [2] - ST Xiangxue (300147) closed at 10.44, down 2.79% with a trading volume of 356,600 shares [2] - Lingrui Pharmaceutical (600285) closed at 23.68, down 1.82% with a trading volume of 170,300 shares [2] Capital Flow Analysis - The Chinese medicine sector experienced a net outflow of 334 million from institutional investors, while retail investors saw a net inflow of 164 million [2][3] - Major stocks like Jizhitang and Tianmu Pharmaceutical had significant net inflows from retail investors, while institutional investors showed mixed interest [3]
中药板块8月25日涨0.47%,天目药业领涨,主力资金净流出3.34亿元